Login / Signup

Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal Women.

Manon CairatMarie Al RahmounMarc J GunterGianluca SeveriLaure DossusAgnès Fournier
Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
Antiplatelet drugs are not good pharmacologic candidates for breast cancer prevention.
Keyphrases
  • postmenopausal women
  • breast cancer risk
  • bone mineral density
  • body composition
  • young adults
  • drug induced